Navigation Links
Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
Date:8/14/2008

>

related to discontinued

operations (net of

income tax of $218,060) - 1,534,476 - 1,155,973

Net (loss) income $(1,570,651) $1,550,919 $(2,911,756) $912,833

(Loss) income per share

from continuing

operations - basic $(0.72) $0.01 $(1.33) $(0.12)

Income per share from

discontinued operations

- basic - 0.74 - 0.56

Net (loss) income per

share - basic $(0.72) $0.75 $(1.33) $0.44

(Loss) income per share

from continuing operations

- diluted $(0.72) $0.01 $(1.33) $(0.12)

Income per share from

discontinued operations -

diluted - 0.67 - 0.56

Net (loss) income per share

- diluted $(0.72) $0.68 $(1.33) $0.44

Weighted average number of

shares used to calculate

(loss) income per share

- basic 2,193,598 2,065,425 2,192,883 2,065,425

Weighted average number of

shares used to calculate

(loss) income per share

- diluted 2,193,598 2,296,930 2,192,883 2,065,425

Consolidated Balance Sheets

June 30, December 31,

ASSETS 2008 2007

CURRENT ASSETS

Cash and cash equivalents $2,835,771 $5,424,486

Accounts receivable 122,958 118,471

Inventories 676,516 172,548

Deposits 15,472 553,483

Prepaid income taxes 58,463 56,863

Income ta
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
2. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
3. Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney
4. RADI Medical Systems Launches Next Generation PressureWire(R) Certus
5. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
6. InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring
7. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
8. Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update
9. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
10. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
11. Pressure BioSciences, Inc. to Discuss 2007 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... England , May 22, 2013 ... novel drug-only formulation of glycopyrronium bromide designed using Prosonix, ... pharmaceutical company developing a portfolio of inhaled Respiratory ... clinical study with PSX1002 that will assess its effect ... of doses in patients with moderate to severe chronic ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Custom ... to reporting eLearning solution using Tin Can API ... dashboard tool. CLD is a leading developer of ... medical device companies worldwide. , Tin Can ... that helps learners and trainers more accurately measure ...
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... 21, 2013 Clinverse, Inc. ... for clinical trials, announced today it has formed ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates ... SpendMD ™, Aggregate Spend Solutions’ recently-launched ... tracking and reporting transfer of value at investigator ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... -- A new type of active metamaterial that incorporates ... ability to have power gain while retaining its negative ... research. "Our simulation and experimental results show that ... only provided gain, but also maintained the negative index ...
... 9, 2011 ARUP Laboratories, pathologist, Ronald L. Weiss, ... the College of American Pathologists at CAP ,11, the ... According to the CAP, the award honors members "who ... care through the specialty of pathology." (Logo: ...
... NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic ... will utilize QTinno®, NewCardio,s automated cardiac safety solution, to ... drug under development for a central nervous system (CNS) ... important aspect of the trial. Clinilabs, located ...
Cached Biology Technology:New metamaterial allows transmission gain while retaining negative refraction property 2ARUP Laboratories' Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 3Clinilabs will Conduct Phase 1 Trial Using QTinno® 4Clinilabs will Conduct Phase 1 Trial Using QTinno® 5
(Date:5/22/2013)... screening for prostate cancer could become as easy for ... to UC Irvine research published today in the ... more than a decade of work, UC Irvine chemists ... markers for prostate cancer in urine, meaning that the ... and at dramatically lower cost. The same technology could ...
(Date:5/21/2013)... have known for a long time that some creatures ... understood, particularly for plants. But it may be that ... National University and the U. S. National Evolutionary Synthesis ... 21 May in the journal Nature Communications , ... genomes. , Drawing from a database of global patterns ...
(Date:5/21/2013)... Wash. A new analysis shows that the nation,s ... of enough algae to produce up to 25 billion ... States, one-twelfth of the country,s yearly needs. , The ... resources that would be needed to grow significant amounts ... results were published in the May 7 issue of ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Small but speedy: Short plants live in the evolutionary fast lane 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... NARRAGANSETT, R.I. August 30, 2010 The ... the University of Rhode Island Graduate School of ... Foundation (NSF) RAPID Response grant through the Foundation,s ... NSF grant, Improving Communication of Oil Spill Research, ...
... It is not an easy task to compare the ... by conventionally fuelled automobiles. The degree to which manufacture, ... the necessary electrical energy are detrimental to the environment ... a team of Empa scientists have made a detailed ...
... MADISON, WI, August 30th, 2010 Undergrads often take ... Iowa State University Department of Horticulture teamed up with ... section to teach students to research and understand literature ... Andrea L. Dinkelman, Jeanine E. Aune, and Gail R. ...
Cached Biology News:Metcalf Institute wins NSF grant to help journalism and communication of oil spill research 2'Greener' than expected 2'Greener' than expected 3Teaching communication and information literacy skills 2
Rabbit polyclonal to Shigella (HRP) ( Abpromise for all tested applications)....
Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Biology Products: